Trade Secret IP Protection & Management EU Summit 2023

Navigating the Legal Landscape for Trade Secret IP: Value, Protection, Litigation and Risk Mitigation Strategy for Innovative Industries

Download The New 2023 Agenda
Brussels, Belgium
14-15 November, 2023

“This was definitely one of the best conferences I have been to. Useful information on best practice; cross-industry speakers; good mix of in-house and law firm attendees and speakers ”

Head of IP, Medincell

Why Attend

What’s the importance of Trade Secret IP Protection & Management to you?

After successfully launching in 2022, Trade Secret IP Protection & Management EU is back for its second edition, expanding into a 2 day event to bring you together with experts from across the globe to address the most immediate industry challenges.

Join us for more practically focused examples and real life case studies including Mulsanne Insurance Company Ltd v Marshmallow Financial Services Ltd and Celgard, LLC v Shenzhen Senior Technology Material, and expert industry views.

Join companies including Valneva, Mnemo TherapeuticsViaccess Orca (Orange Group), Enel GroupMerckØrsted and many more . . . 

By attending this event you will gain the latest knowledge to preserve confidentiality, reduce the risk of misappropriation and maintain a competitive edge in an ever-competitive marketplace.

This is a must-attend event for anyone working within industry IP, legal, cyber security, HR and compliance functions.

Highlights Include

  1. Reviewing recent European trade secret cases to discover the latest legal nuances and how they impact industry in-house executives
  2. Devising a successful in-house trade secret management and risk mitigation strategy
  3. Optimising your internal cyber framework by understanding the importance of privacy, data and cyber security for trade secret IP protection
  4. Identifying your company’s commercial value and exploring how to audit your company’s trade secret IP
  5. Establishing the importance of trade secret IP in anticipation of the Rise of AI

Partner With Us

Interested in how you can get involved with Trade Secret IP Protection & Management 2023?

Based on your objectives, we can create bespoke packages for you. From presenting your expertise on stage to partnering with us to deliver networking activities. Partner with us in 2023 to showcase your brand and make valuable new connections. Opportunities include thought leadership, branding, and networking.

Discuss your objectives with Duncan Henderson, Senior Commercial Partnerships Manager, [email protected]

PARTNER WITH US

Key Statistics

100+
Attendees
25+
Speakers
60%
In-House Counsel
6
Hours of dedicated networking time

Trade Secret Pre-Conference Workshop

Monday 13th November 2023

Trade Secret IP Protection is quickly becoming a priority for in-house IP and legal counsels looking for optimal and cost-effective IP protection strategies. Enrich your experience at our event with exclusive pre-conference masterclasses to gain in-depth, interactive solutions to immediate Trade Secret IP challenges in the field.

REGISTER NOW AND THE FIRST 20 IN-HOUSE CONFERENCE REGISTRANTS RECEIVE WORKSHOP ADMISSION FOR NO EXTRA COST

Add our pre-conference masterclass to your ticket upon registration or register for the workshops separately by clicking below:

Register Your Place

Workshop A | 09:00 – 12:00

Part 1 | Effective Collaboration: R&D and Technology

Part 2 | Effective Collaboration: Compliance

Part 3 | Trade Secret Risk Mitigation Technology

Workshop B | 13:30 – 16:30

Part 1 | Trade Secret Auditing

Part 2 | Cross-Border Risks and Legal Obligation

Download The Official 2023 Event Schedule

Reasons For You To Attend Trade Secret IP Protection & Management Europe 2023:

  1. A uniquely cross-industry-focused event to highlight benchmarking opportunities across all areas of IP and trade secrets, which are having an increasingly real-world impact
  2. Participate in interactive panel sessions and roundtable discussions to share your expertise, and form business connections with IP leaders and legal experts with our professional networking opportunities
  3. Over 60% of attendees from in-house positions, examining trade secret IP developments in Europe and the US
  4. Bringing together private practice and in-house to discuss the latest challenges, as well as trade secrets and IP management priorities, to help you remain ahead of the competition

From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick above.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

For more information on key datessponsorswebinars, virtual and in-person roundtables and other ways to get involved in the Global IP Series, download the 2023/2024 Marketing Solutions brochure below.

DOWNLOAD THE BROCHURE

If you have any questions, please get in touch and our Marketing team will get back to you.

CONTACT US

Kisaco IP Advisory Board

Author:

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

Dr. Leslie Fischer

Principal Patent Attorney
Sandoz

Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

Author:

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB

Author:

Corinna Sundermann

Senior Vice President Intellectual Property
bei Fresenius Kabi Deutschland GmbH

Corinna Sundermann has been heading the IP department of the Pharma Division at Fresenius Kabi. She joined Fresenius Kabi in 2008 as a Manager and built the IP department from 1 to 30 FTE since then. She has been the Senior Vice President since 2012. Her focus is on generics, branded products, clinical nutrition and medical devices. Before joining Fresenius Kabi, she worked 10 years for an originator company, 5 years as a Head of Combinatorial Chemistry, 5 years in the IP department and has been a European Patent Attorney since 2006. She holds a Dr. rer. nat. from the University of Jena and a diploma in chemistry from the University of Frankfurt.

Corinna Sundermann

Senior Vice President Intellectual Property
bei Fresenius Kabi Deutschland GmbH

Corinna Sundermann has been heading the IP department of the Pharma Division at Fresenius Kabi. She joined Fresenius Kabi in 2008 as a Manager and built the IP department from 1 to 30 FTE since then. She has been the Senior Vice President since 2012. Her focus is on generics, branded products, clinical nutrition and medical devices. Before joining Fresenius Kabi, she worked 10 years for an originator company, 5 years as a Head of Combinatorial Chemistry, 5 years in the IP department and has been a European Patent Attorney since 2006. She holds a Dr. rer. nat. from the University of Jena and a diploma in chemistry from the University of Frankfurt.

Author:

Fredrik Fredh

Intellectual Property Counsel
iff

Fredrik is a qualified European Patent Attorney and experienced international IP strategist. Having completed academic studies of innovation and entrepreneurship processes, as well as IP law and management, he has a good grasp of various intellectual property rights (IPR).

Thanks to his many years as IP professional in the Pharma and Biotech industry, Fredrik has learnt to use this IPR toolbox to pursue his professional passion; maximizing return on investment for innovation.”

Fredrik Fredh

Intellectual Property Counsel
iff

Fredrik is a qualified European Patent Attorney and experienced international IP strategist. Having completed academic studies of innovation and entrepreneurship processes, as well as IP law and management, he has a good grasp of various intellectual property rights (IPR).

Thanks to his many years as IP professional in the Pharma and Biotech industry, Fredrik has learnt to use this IPR toolbox to pursue his professional passion; maximizing return on investment for innovation.”

Author:

Frank Landolt

Chief Counsel, Intellectual Property and Legal
Confo Therapeutics

Frank Landolt is Chief Counsel, Intellectual Property and Legal at Confo Therapeutics, a privately held biopharmaceutical start-up based in Ghent, Belgium specializing in GPCR-targeted therapeutics.

After studying chemistry and law at the University of Leiden in the Netherlands, Frank worked for almost ten years on pharmaceutical and biotechnological patents and licensing in private practice in the Netherlands, where his clients included major pharmaceutical companies as well as some of the top biotech firms and research institutions in the Netherlands.

Prior to joining Confo in 2018, Frank worked for fifteen years in Ablynx N.V. (now a wholly owned Sanofi company), where he was a member of the management team and headed an integrated IP and legal group of four lawyers and five patent professionals. At Ablynx, Frank was involved in negotiating Ablynx’s strategic partnerships and licensing deals with AbbVie, Boehringer-Ingelheim, MSD, Merck-Serono, Novartis, Novo Nordisk, Sanofi, and Wyeth.

From 2000 to 2004, Frank was director of IP and legal counsel at Devgen N.V. (now part of Syngenta), another Ghent-based biotechnology company, where he was involved in negotiating Devgen’s strategic collaborations with Sumitomo, Monsanto, and DuPont Pioneer.

Frank is a Dutch and European patent attorney and also holds a degree in business law from the University of Antwerp. He is a member of the Dutch association of patent attorneys (where he is a tutor for the professional qualification course), EPI, and LES Benelux (where he is involved in the LES Licensing Course). He is a regular speaker on a range of topics relating to IP and licensing in the (bio)pharmaceutical sector. Frank was named as one of Managing IP’s ‘Corporate IP stars’ for four years in a row (2015-2018).

Frank Landolt

Chief Counsel, Intellectual Property and Legal
Confo Therapeutics

Frank Landolt is Chief Counsel, Intellectual Property and Legal at Confo Therapeutics, a privately held biopharmaceutical start-up based in Ghent, Belgium specializing in GPCR-targeted therapeutics.

After studying chemistry and law at the University of Leiden in the Netherlands, Frank worked for almost ten years on pharmaceutical and biotechnological patents and licensing in private practice in the Netherlands, where his clients included major pharmaceutical companies as well as some of the top biotech firms and research institutions in the Netherlands.

Prior to joining Confo in 2018, Frank worked for fifteen years in Ablynx N.V. (now a wholly owned Sanofi company), where he was a member of the management team and headed an integrated IP and legal group of four lawyers and five patent professionals. At Ablynx, Frank was involved in negotiating Ablynx’s strategic partnerships and licensing deals with AbbVie, Boehringer-Ingelheim, MSD, Merck-Serono, Novartis, Novo Nordisk, Sanofi, and Wyeth.

From 2000 to 2004, Frank was director of IP and legal counsel at Devgen N.V. (now part of Syngenta), another Ghent-based biotechnology company, where he was involved in negotiating Devgen’s strategic collaborations with Sumitomo, Monsanto, and DuPont Pioneer.

Frank is a Dutch and European patent attorney and also holds a degree in business law from the University of Antwerp. He is a member of the Dutch association of patent attorneys (where he is a tutor for the professional qualification course), EPI, and LES Benelux (where he is involved in the LES Licensing Course). He is a regular speaker on a range of topics relating to IP and licensing in the (bio)pharmaceutical sector. Frank was named as one of Managing IP’s ‘Corporate IP stars’ for four years in a row (2015-2018).

Author:

Mathilde Rauline

Head of Greater Europe Patent Litigation
Sanofi

Mathilde is a European patent attorney, is qualified as a French patent attorney, and is admitted to the Paris bar.

She is head of Greater Europe patent litigation at Sanofi, after having been a patent litigator in private practice (mostly in the pharmaceutical field), and a patent attorney in the industry (Sanofi, Nestlé).

She has extensive experience in pharmaceutical and life-science patent litigation in France, at the EPO, in Europe, and in Eurasia.

Her expertise also comprises contractual matters, settlements, regulatory aspects, and the SPC regulation.

Mathilde Rauline

Head of Greater Europe Patent Litigation
Sanofi

Mathilde is a European patent attorney, is qualified as a French patent attorney, and is admitted to the Paris bar.

She is head of Greater Europe patent litigation at Sanofi, after having been a patent litigator in private practice (mostly in the pharmaceutical field), and a patent attorney in the industry (Sanofi, Nestlé).

She has extensive experience in pharmaceutical and life-science patent litigation in France, at the EPO, in Europe, and in Eurasia.

Her expertise also comprises contractual matters, settlements, regulatory aspects, and the SPC regulation.

Author:

Lorenz Kallenbach

Senior Corporate Patent Counsel (Director)
Merck

Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.

Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.

Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.

Lorenz Kallenbach

Senior Corporate Patent Counsel (Director)
Merck

Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.

Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.

Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.

Author:

Stephan Kutik

Director, Intellectual Property
Genevant Sciences GmbH

Stephan Kutik

Director, Intellectual Property
Genevant Sciences GmbH

Author:

Ewan Nettleton

Principal IP Counsel, Oncology Litigation
Novartis Pharma AG

Ewan Nettleton

Principal IP Counsel, Oncology Litigation
Novartis Pharma AG

Author:

Mike Cottler

Global Head of Litigation
Alvotech

Mike Cottler

Global Head of Litigation
Alvotech

CROSS-INDUSTRY IN-HOUSE AND EXECUTIVES INCLUDING:

Don't Just Take Our Word, Listen To What Your Industry Peers Have To Say!

Previous Series Attendees Include

AUDIENCE BREAKDOWN

60%
Industry In-House
30%
Law Firms | Consultants
10%
Vendors

Industry In-House

Law Firms | Consultants

Vendors

2023 Speakers

 

Adrian Spillmann

Director of Intellectual Property
Valneva

Adrian Spillmann is Director of Corporate Intellectual Property for the Valneva group (a European biotech company focusing on vaccines) in Vienna, Austria, and specializes in patent and trademark prosecution, patent and trademark enforcement, patent drafting, patent portfolio management, in house patent counseling, patent monetization and intellectual property transactions in biotechnology and pharmaceuticals and other life science projects.

Adrian Spillmann

Director of Intellectual Property
Valneva

Adrian Spillmann

Director of Intellectual Property
Valneva

Adrian Spillmann is Director of Corporate Intellectual Property for the Valneva group (a European biotech company focusing on vaccines) in Vienna, Austria, and specializes in patent and trademark prosecution, patent and trademark enforcement, patent drafting, patent portfolio management, in house patent counseling, patent monetization and intellectual property transactions in biotechnology and pharmaceuticals and other life science projects.

His areas of expertise include protection of prophylactics, therapeutics, and diagnostics for infectious diseases, immunological disorders, cancerous diseases, neurodegenerative disorders and metabolic disorders, vaccine technologies, antibody technologies, production of biological and chemical compounds, new medical uses, and formulations of known compounds.

After earning his Ph.D. at the University of Zurich, Switzerland, Adrian was a Consultant at Deloitte, followed by a 7-year stay in various positions in the patent department at Novartis. Furthermore, Adrian was Senior Patent Attorney at Ablynx, an antibody company in Belgium, for three years.

Adrian is a European and Swiss-registered patent attorney and received his LLM from the University of Law in London.

 

Bart Goddyn

General Counsel & Company Secretary
Mnemo Therapeutics

Bart Goddyn

General Counsel & Company Secretary
Mnemo Therapeutics

Bart Goddyn

General Counsel & Company Secretary
Mnemo Therapeutics
 

Caterina Strippoli

Head of Intellectual Property
Enel Group

Caterina Strippoli

Head of Intellectual Property
Enel Group

Caterina Strippoli

Head of Intellectual Property
Enel Group
 

Christine Maury Panis

EVP, General Counsel and Security
Viaccess Orca (Orange Group)

Christine Maury Panis

EVP, General Counsel and Security
Viaccess Orca (Orange Group)

Christine Maury Panis

EVP, General Counsel and Security
Viaccess Orca (Orange Group)
 

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB

Christof Bull

Assistant General Patent Counsel
UCB
 

Don McCombie

Partner
Clifford Chance

Don McCombie is a partner in the London IP group at Clifford Chance. He advises on all aspects of IP law, in particular technical trade secrets and patent disputes. In recent years, Don has brought and defended trade secrets claims relating to technologies including cryptocurrency trading software, semiconductor designs, antibody libraries, fire-resistant coatings and liners for train gondola wagons, as well as business information and datasets.

Don McCombie

Partner
Clifford Chance

Don McCombie

Partner
Clifford Chance

Don McCombie is a partner in the London IP group at Clifford Chance. He advises on all aspects of IP law, in particular technical trade secrets and patent disputes. In recent years, Don has brought and defended trade secrets claims relating to technologies including cryptocurrency trading software, semiconductor designs, antibody libraries, fire-resistant coatings and liners for train gondola wagons, as well as business information and datasets. Don also regularly advises on the licensing and transfer of trade secrets and know-how and on practical strategies for protecting information and reducing the risk of trade secrets theft.

 

Dr. Sam Williams

Head of IP
Siemens

Dr. Sam Williams

Head of IP
Siemens

Dr. Sam Williams

Head of IP
Siemens
 

Dr. Stefan Horstmann

VP of PS Core - Patents and Scientific Services
Merck KGaA

Dr. Stefan Horstmann is VP of PS Core - Patents and Scientific Services at Merck KGaA.

Dr. Horstmann holds a PhD in Chemistry and is qualified as European and German Patent Attorney. Before becoming a VP of PS Core, he previously served as Head of the Patents B2B Department, and has also served as in-house patent attorney at Merck KGaA and Henkel KGaA and as an IT consultant at SerCon GmbH.

Dr. Stefan Horstmann

VP of PS Core - Patents and Scientific Services
Merck KGaA

Dr. Stefan Horstmann

VP of PS Core - Patents and Scientific Services
Merck KGaA

Dr. Stefan Horstmann is VP of PS Core - Patents and Scientific Services at Merck KGaA.

Dr. Horstmann holds a PhD in Chemistry and is qualified as European and German Patent Attorney. Before becoming a VP of PS Core, he previously served as Head of the Patents B2B Department, and has also served as in-house patent attorney at Merck KGaA and Henkel KGaA and as an IT consultant at SerCon GmbH.

Dr. Horstmann is a member of the European Patent Institute (EPI), the German Chemical Society (GDCh) and the Association of Intellectual Property Experts (VPP). He represents Merck to matters of intellectual property law at the European Chemical Industry Council (CEFIC) and the German Chemical Industry Association (VCI).

 

Fredrick de Mare

Head of Intellectual Property
MedinCell

Fredrick de Mare

Head of Intellectual Property
MedinCell

Fredrick de Mare

Head of Intellectual Property
MedinCell
 

Kora Knuchel

Chief IP and Legal Officer (CIPLO)
Biognosys AG

Kora Knuchel

Chief IP and Legal Officer (CIPLO)
Biognosys AG

Kora Knuchel

Chief IP and Legal Officer (CIPLO)
Biognosys AG
 

Lena Pauschenwein

Legal Officer
DG Grow | European Commission

Lena PAUSCHENWEIN, Legal Officer, Directorate-General GROW - Internal Market, Industry, Entrepreneurship and SMEs, European Commission, Brussels, Belgium

Lena Pauschenwein is a jurist specialised in intellectual property law and works in the Intangible Economy Unit of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) of the European Commission.

Lena Pauschenwein

Legal Officer
DG Grow | European Commission

Lena Pauschenwein

Legal Officer
DG Grow | European Commission

Lena PAUSCHENWEIN, Legal Officer, Directorate-General GROW - Internal Market, Industry, Entrepreneurship and SMEs, European Commission, Brussels, Belgium

Lena Pauschenwein is a jurist specialised in intellectual property law and works in the Intangible Economy Unit of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) of the European Commission.

Lena holds law degrees from the University of Vienna (Magister iuris) and the University of Glasgow (LLM), both with a focus on intellectual property and technology law. Prior to joining the European Commission in 2021, she worked at the Austrian Supervisory Authority for Collective Management Organisations.

 

Lilian Mocelin

Senior Intellectual Property Manager
Umdasch Group AG

Lilian Mocelin

Senior Intellectual Property Manager
Umdasch Group AG

Lilian Mocelin

Senior Intellectual Property Manager
Umdasch Group AG
 

Mark Chadwick

Head of IP
Meatable

Mark Chadwick

Head of IP
Meatable

Mark Chadwick

Head of IP
Meatable
 

Olivier Lemaire

General Counsel and Compliance Officer
Ziphius Vaccines

Olivier Lemaire

General Counsel and Compliance Officer
Ziphius Vaccines

Olivier Lemaire

General Counsel and Compliance Officer
Ziphius Vaccines
 

Pascal van Troost

Global Intellectual Property Leader
Punch Powertrain

Pascal van Troost is an all round IP leader with a can do mindset. He is a qualified patent attorney and holds a master degree in Engineering and a master degree in IP Law & Management.  He has working experience in private practice as well in the industry. Currently he is working at Punch Powertrain, a company which develops powertrains for vehicles including hybrid and electric powertrains. At Punch Powertrain he is the corporate responsible for all Intellectual Property matters at Punch.

Pascal van Troost

Global Intellectual Property Leader
Punch Powertrain

Pascal van Troost

Global Intellectual Property Leader
Punch Powertrain

Pascal van Troost is an all round IP leader with a can do mindset. He is a qualified patent attorney and holds a master degree in Engineering and a master degree in IP Law & Management.  He has working experience in private practice as well in the industry. Currently he is working at Punch Powertrain, a company which develops powertrains for vehicles including hybrid and electric powertrains. At Punch Powertrain he is the corporate responsible for all Intellectual Property matters at Punch. This includes activities with regards to IP strategy development, stimulating innovation, creation of IP awareness, IP protection, IP portfolio management, IP litigation, IP monetization, IP risk reduction, IP contracting, IP intelligence and information security.

 

Preben Kjær Kristensen

Senior Lead IPR Specialist
Ørsted

Preben Kjær Kristensen has an Engineering Degree from Denmark’s Technical University supplemented with an Executive MBA from Copenhagen Business School. He is currently working at Ørsted Wind Power A/S as Head of IP.
Ørsted Wind Power develops, builds, and operates onshore and offshore wind turbine parks in Europe (North and Baltic Sea), Taiwan and the United States as well as energy storage (Power-to-X solutions, Carbon Capture and Storage, etc.).

Preben Kjær Kristensen

Senior Lead IPR Specialist
Ørsted

Preben Kjær Kristensen

Senior Lead IPR Specialist
Ørsted

Preben Kjær Kristensen has an Engineering Degree from Denmark’s Technical University supplemented with an Executive MBA from Copenhagen Business School. He is currently working at Ørsted Wind Power A/S as Head of IP.
Ørsted Wind Power develops, builds, and operates onshore and offshore wind turbine parks in Europe (North and Baltic Sea), Taiwan and the United States as well as energy storage (Power-to-X solutions, Carbon Capture and Storage, etc.).


Mr. Kristensen has more than 20 years of IPR experience from among others Nokia in different positions and the Technical University of Denmark with tech transfer and business development.


Mr. Kristensen is Chairman of the Board for the Danish Industry’s Patent and Trademark Executives and acts as a Technical Judge at the Danish Maritime and Trade Court in patent litigation cases.

 

Shane O`Neill

Assistant General Counsel
Norsk Titanium

Shane O`Neill

Assistant General Counsel
Norsk Titanium

Shane O`Neill

Assistant General Counsel
Norsk Titanium
 

Stefan Braun

Senior Legal Counsel IT
Leoni

Stefan Braun

Senior Legal Counsel IT
Leoni

Stefan Braun

Senior Legal Counsel IT
Leoni
 

Tilman Breitenstein

CEO
Scalable IP

Tilman Breitenstein

CEO
Scalable IP

Tilman Breitenstein

CEO
Scalable IP

Register

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

Ticket price will increase after

— July 14, 2023 —

Wednesday, June 7, 2023 to Friday, July 14, 2023
Industry In-House | Regulatory Officials
€699
Super Super Early Bird Rate
Tuesday, May 9, 2023 to Friday, July 14, 2023
Law Firms | Consultants
€999
Super Super Early Bird Rate
Tuesday, May 9, 2023 to Friday, July 14, 2023
Software Providers
€1999
Super Super Early Bird Rate
Tuesday, May 9, 2023 to Wednesday, November 15, 2023
Workshop A - Effective Collaboration
€350
Standard Rate
Tuesday, May 9, 2023 to Wednesday, November 15, 2023
Workshop B - Valuating Your Trade Secret Worth
€350
Standard Rate
Preparing registration...

Gold Partners

Media Partners

Resources

Download Resource

Partner with Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Contact Us

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.